Glycemic variability and cardiovascular disease in patients with type 2 diabetes

Glycated hemoglobin is currently the gold standard for assessment of long-term glycemic control and response to medical treatment in patients with diabetes. Glycated hemoglobin, however, does not address fluctuations in blood glucose. Glycemic variability (GV) refers to fluctuations in blood glucose...

Descripción completa

Detalles Bibliográficos
Autores principales: Martinez, Marcela, Santamarina, Jimena, Pavesi, Adrian, Musso, Carla, Umpierrez, Guillermo E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Cardiovascular and Metabolic Risk
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993171/
https://www.ncbi.nlm.nih.gov/pubmed/33762313
http://dx.doi.org/10.1136/bmjdrc-2020-002032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993171/
https://www.ncbi.nlm.nih.gov/pubmed/33762313
http://dx.doi.org/10.1136/bmjdrc-2020-002032

Ejemplares similares